BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Čelešnik H, Potočnik U. Peripheral Blood Transcriptome in Breast Cancer Patients as a Source of Less Invasive Immune Biomarkers for Personalized Medicine, and Implications for Triple Negative Breast Cancer. Cancers (Basel) 2022;14:591. [PMID: 35158858 DOI: 10.3390/cancers14030591] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kunadirek P, Pinjaroen N, Nookaew I, Tangkijvanich P, Chuaypen N. Transcriptomic Analyses Reveal Long Non-Coding RNA in Peripheral Blood Mononuclear Cells as a Novel Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma. Int J Mol Sci 2022;23:7882. [PMID: 35887228 DOI: 10.3390/ijms23147882] [Reference Citation Analysis]
2 Chauhan P, Bhargava A, Kumari R, Ratre P, Tiwari R, Kumar Srivastava R, Yu Goryacheva I, Kumar Mishra P. Surface-enhanced Raman scattering biosensors for detection of oncomiRs in breast cancer. Drug Discov Today 2022:S1359-6446(22)00163-5. [PMID: 35460892 DOI: 10.1016/j.drudis.2022.04.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Vietri MT, D’elia G, Caliendo G, Albanese L, Signoriello G, Napoli C, Molinari AM. Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation. Genes 2022;13:321. [DOI: 10.3390/genes13020321] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]